The evolution of personalized healthcare and the pivotal role of European regions in its implementation

Personalized medicine (PM) moves at the same pace of data and technology and calls for important changes in healthcare. New players are participating, providing impulse to PM. We review the conceptual foundations for PM and personalized healthcare and their evolution through scientific publications where a clear definition and the features of the different formulations are identifiable. We then examined PM policy documents of the International Consortium for Personalised Medicine and related initiatives to understand how PM stakeholders have been changing. Regional authorities and stakeholders have joined the race to deliver personalized care and are driving toward what could be termed as the next personalized healthcare. Their role as a key stakeholder in PM is expected to be pivotal.

Automated summary

Personalized medicine is advancing the healthcare field with the development of data and technology, with various stakeholders playing a key role in its evolution. Policy documents and initiatives from the International Consortium for Personalised Medicine reveal the changing trends among stakeholders in personalized medicine, with regional authorities and stakeholders accelerating towards personalized care. Their involvement is seen as pivotal in the future of personalized medicine.